Previous 10 | Next 10 |
Alina ® pen injector platform is now available for several new therapeutic areas Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension...
A group of analysts from KeyBank Capital Markets has named several life sciences companies that could benefit from renewed demand for PCR tests and COVID-19 vaccines after the emergence of the newly detected Omicron variant. While noting that it is too early to identify the impact of the vari...
New Flagship Building to Host Syringe Production Lines, R&D and Offices Stevanato Group (NYSE: STVN) (“the Company”), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life science...
Stevanato Group S.p.A. (STVN) Q3 2021 Earnings Conference Call November 9, 2021 8:30 a.m. ET Company Participants Lisa Miles - Head of Investor Relations Franco Stevanato - Executive Chairman Franco Moro - Chief Executive Officer and Chief Operating Officer Marco Dal Lago - Chief Financial Of...
Image source: The Motley Fool. Stevanato Group S.p.A. (NYSE: STVN) Q3 2021 Earnings Call Nov 09, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Stevanato Group S.p.A. (STVN) Q3 2021 Earnings Call Transcript
(NYSE:STVN): Q3 GAAP EPS of $0.07 misses by $0.04. Revenue of $214.5M (+36.5% Y/Y) misses by $23.01M. Press Release For further details see: EPS misses by $0.04, misses on revenue
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter 2021. Third Quarter 2021 High...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the third quarter of fiscal 2021 on Tu...
Stevanato Group (NYSE:STVN) (“the Company”), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has been recognized as a winner of Pharma Manufacturing magazine’s 2021 ...
Construction on Fishers, Indiana plant to commence this month and is expected to be completed in 2023 State-of-the-art manufacturing operations to enable Stevanato Group to better serve North America pharmaceutical customers Stevanato Group (NYSE:STVN), a glo...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...